CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 727 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 984 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 991 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,617 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,034 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 5,321 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 2,084 shares (to pay taxes)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,944 shares at $23.11 ($368,466)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 20,343 shares at $23.10 ($469,923)
- 4 Grant or award CHIEF COMMERCIAL OFFICER acquired 1,118 shares (grant or award)
- 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 469 shares (grant or award)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 577 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 2,004 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 507 shares (to pay taxes)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 9,051 shares at $22.45 ($203,195)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 36,372 shares at $22.25 ($809,277)
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,409 shares at $21.06 ($261,334)
- 4 Planned sale CHIEF OPERATING OFFICER sold 14,000 shares at $19.57 ($273,980)
- 4 Planned sale CHIEF OPERATING OFFICER sold 14,000 shares at an average $18.24 ($255,413)
Page 7 of 20 · 386 filings